SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today announced that Daniel Swisher, Sunesis’ Chief Executive Officer and President, will present a corporate update at the upcoming 10th Annual BIO CEO & Investor Conference at 11:45 a.m. Eastern Time on Tuesday, February 12, 2008 at the Waldorf Astoria in New York City, NY.
Interested parties may access a webcast of the presentation by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks until February 26, 2008.
About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
CONTACT: Investors, Eric Bjerkholt, SVP, Corp. Development & Finance of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or Media, Karen L. Bergman
or Michelle Corral, both of BCC Partners, +1-650-575-1509, or
+1-415-794-8662, for Sunesis Pharmaceuticals, Inc.
Web site: http://www.sunesis.com/
